Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK

Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106.

Authors

D R Newell¹, K M Searle, N B Westwood, S S Burtles; Cancer Research UK Phase I/II Clinical Trials Committee

Affiliation

¹ Northern Institute for Cancer Research, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.

No abstract available

Publication types

Biography
Historical Article

MeSH terms

Antineoplastic Agents / history*
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use
Clinical Trials Data Monitoring Committees / history*
Clinical Trials, Phase I as Topic / history*
Clinical Trials, Phase II as Topic / history*
Financing, Government / history
Health Policy / history
History, 20th Century
Humans
International Cooperation / history
Neoplasms / drug therapy
Neoplasms / history*
Research Design
United Kingdom

Substances

Antineoplastic Agents

Personal name as subject

Tom Connors